Related Experiment Videos
Eosinophil chemotactic factor-L (ECF-L): a novel osteoclast stimulating factor
Yasuo Oba1, Ho Yeon Chung, Sun Jin Choi
1Department of Medicine/Hematology-Oncology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Summary
Eosinophil chemotactic factor-L (ECF-L) enhances osteoclast formation and function without affecting RANKL levels. Neutralizing ECF-L inhibits osteoclastogenesis, highlighting its role in bone remodeling.
Area of Science:
- Cell Biology
- Immunology
- Bone Biology
Background:
- Osteoclastogenesis is crucial for bone remodeling and is tightly regulated by molecular mechanisms.
- Investigating these mechanisms requires pure osteoclast (OCL) populations.
- An immortalized OCL precursor cell line was developed for this purpose.
Purpose of the Study:
- To identify novel factors involved in osteoclastogenesis.
- To elucidate the role of Eosinophil Chemotactic Factor-L (ECF-L) in OCL formation and function.
- To understand the relationship between ECF-L and RANKL signaling.
Main Methods:
- Developed an immortalized OCL precursor cell line.
- Utilized PCR selective cDNA subtraction to identify OCL-expressed genes.
- Assessed OCL formation and function in vitro using conditioned media, purified proteins, and neutralizing antibodies.
- Performed chemotaxis and in situ hybridization assays.
Main Results:
- ECF-L was identified as a gene highly expressed in mature OCLs.
- ECF-L enhanced OCL formation and bone resorption in a dose-dependent manner.
- ECF-L promoted OCL precursor migration and acted at later stages of OCL formation.
- Neutralizing ECF-L inhibited RANKL- and 1,25(OH)2D3-induced OCL formation, independent of RANKL levels.
Conclusions:
- ECF-L is a novel and potent mediator of osteoclastogenesis.
- ECF-L enhances OCL formation and function, particularly in later stages.
- ECF-L plays a significant role in osteoclastogenesis, potentially independent of RANKL induction.